Ledger.Open graph →
SEC Form D · filed August 9, 2024

Chemomab Therapeutics Ltd

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
TEL AVIV, L3
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Claude C. Nicaise · Cheshire, CTDirectorNeil H. Cohen · Cambridge, MADirectorAlan C. Moses · Tel Aviv, L3DirectorDean Delisle · Macclenny, FLDirectorLarry Braden · Macclenny, FLDirectorJill H. Quigley · Tel Aviv, L3DirectorSigal Fattal · Ramat Gan, L3ExecAdi Mor · Tel Aviv, L3Exec · DirectorMatthew Frankel · Tel Aviv, L3ExecNissim Darvish · Tel Aviv, L3DirectorWhitney Imeraj · Atlanta, GADirectorAnthony Cox · Atlanta, GADirectorJill H. Quigley · Tel Aviv, L3DirectorSigal Fattal · Ramat Gan, L3ExecAdi Mor · Tel Aviv, L3Exec · DirectorAlan C. Moses · Tel Aviv, L3DirectorMatthew Frankel · Tel Aviv, L3ExecNissim Darvish · Omer, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗